These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27127104)

  • 21. [The role of serotonin in the pathophysiology of migraine].
    Szczudlik A
    Neurol Neurochir Pol; 1992; Suppl 2():14-27. PubMed ID: 1337765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migraine: current therapeutic targets and future avenues.
    Arulmozhi DK; Veeranjaneyulu A; Bodhankar SL
    Curr Vasc Pharmacol; 2006 Apr; 4(2):117-28. PubMed ID: 16611154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development.
    Barbanti P; Aurilia C; Egeo G; Fofi L; Palmirotta R
    Expert Opin Investig Drugs; 2017 Mar; 26(3):269-277. PubMed ID: 28103158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine.
    Levy D; Burstein R; Strassman AM
    Ann Neurol; 2005 Nov; 58(5):698-705. PubMed ID: 16240341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of peripheral and spinal 5-HT2B receptors in formalin-induced nociception.
    Cervantes-Durán C; Vidal-Cantú GC; Barragán-Iglesias P; Pineda-Farias JB; Bravo-Hernández M; Murbartián J; Granados-Soto V
    Pharmacol Biochem Behav; 2012 Jul; 102(1):30-5. PubMed ID: 22476011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Migraine pain: reflections against vasodilatation.
    Panconesi A; Bartolozzi ML; Guidi L
    J Headache Pain; 2009 Oct; 10(5):317-25. PubMed ID: 19499287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histamine in migraine and brain.
    Alstadhaug KB
    Headache; 2014 Feb; 54(2):246-59. PubMed ID: 24433203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model.
    Knyihár-Csillik E; Tajti J; Chadaide Z; Csillik B; Vécsei L
    Microsc Res Tech; 2001 May; 53(3):193-211. PubMed ID: 11301495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide mechanisms in migraine.
    Olesen J; Jansen-Olesen I
    Pathol Biol (Paris); 2000 Sep; 48(7):648-57. PubMed ID: 11072643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of serotonin and other neuroactive molecules in the physiopathogenesis of migraine. Current hypotheses].
    Hamon M; Bourgoin S
    Pathol Biol (Paris); 2000 Sep; 48(7):619-29. PubMed ID: 11072640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
    Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
    Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 5-hydroxytryptamine-nitric oxide connection: the key link in the initiation of migraine?
    Fozard JR
    Arch Int Pharmacodyn Ther; 1995; 329(1):111-9. PubMed ID: 7639613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors.
    Tajti J; Csáti A; Vécsei L
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1509-20. PubMed ID: 25253587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurogenic inflammation and migraine: implications for the therapeutics.
    Peroutka SJ
    Mol Interv; 2005 Oct; 5(5):304-11. PubMed ID: 16249526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
    Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR
    Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of endothelial and neuronal nitric oxide synthase in dura and pia mater after air stress.
    Zinck T; Illum R; Jansen-Olesen I
    Cephalalgia; 2006 Jan; 26(1):14-25. PubMed ID: 16396662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions.
    Moskowitz MA; Buzzi MG
    J Neurol; 1991; 238 Suppl 1():S18-22. PubMed ID: 2045826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives.
    Fozard JR; Kalkman HO
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):225-9. PubMed ID: 7824037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meningeal afferent signaling and the pathophysiology of migraine.
    Burgos-Vega C; Moy J; Dussor G
    Prog Mol Biol Transl Sci; 2015; 131():537-64. PubMed ID: 25744685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.